Arthritis is a chronic Immune-Mediated Inflammatory Disorder which consists of more than 100 rheumatic diseases that affect joints, the tissues which surround joints and other connective tissue.
Arthritis has been a burden to patients since it could lead to pain, disability, and even worse results. It could also affect other parts of the human body including eyes, mouth or lungs.
While the cause of certain arthritis is not clear yet, it is certain that arthritis affects plenty of people all over the world. In the United States, there are 52.5 millions of people suffering from the disease.
300,000 children in the US are affected by juvenile arthritis – that’s 1 in 250 children under the age of 18.
At Worldwide Clinical Trials, our experts understand that the commercial viability of therapeutics for chronic inflammatory disorders is influenced by a range of factors, including perceived value and therapeutic novelty — which is particularly relevant for illnesses with established treatments like arthritis.